Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Mar 04, 2024 | |||||||
GSE202588 |
3D reconstruction of the mouse cochlea from scRNA-seq data suggests morphogen-based principles in apex-to-base specification
|
4 | Joerg Waldhaus | Mar 04, 2024 | ||||
GSE260504 |
ATAC-seq of TNF-alpha activation in HEK cells with or without TRAFTAC against NfkB
|
4 | Pierre-Luc Germain | Mar 04, 2024 | ||||
GSE197569 |
Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumors
|
31 | Kirsi Rautajoki | Mar 04, 2024 | ||||
GSE212291 |
Analysis of exosomal miRNAs in MCF7 cells regulated by LSD1
|
9 | Xin Hu | Mar 04, 2024 | ||||
GSE218200 |
Analysis of miRNAs in MCF7 cells regulated by LSD1
|
9 | Xin Hu | Mar 04, 2024 | ||||
GSE260816 |
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
|
46 | Xiangnan Guan | Mar 04, 2024 | ||||
GSE260599 |
Anti-tumor activity of a novelLAIR1antagonist in combination with anti-PD-1to treat collagen-rich solid tumors
|
61 | Lee Benjamin Rivera | Mar 04, 2024 | ||||
GSE260598 |
Anti-tumor activity of a novelLAIR1antagonist in combination with anti-PD-1to treat collagen-rich solid tumors (GeoMx)
|
48 | Lee Benjamin Rivera | Mar 04, 2024 | ||||
GSE260597 |
Anti-tumor activity of a novelLAIR1antagonist in combination with anti-PD-1to treat collagen-rich solid tumors (human)
|
6 | Lee Benjamin Rivera | Mar 04, 2024 | ||||
GSE260596 |
Anti-tumor activity of a novelLAIR1antagonist in combination with anti-PD-1to treat collagen-rich solid tumors (mouse)
|
7 | Lee Benjamin Rivera | Mar 04, 2024 | ||||
GSE253769 |
Autophagy-enhancing ATG16L1 polymorphism improves clinical outcomes and promotes superior T-cell immunity in chronic HIV-1 infection
|
32 | Carla Ribeiro | Mar 04, 2024 | ||||
GSE244568 |
BCL-2 modulates IRE1a activation to attenuate ER stress and pulmonary fibrosis
|
2 | Jaymin J Kathiriya | Mar 04, 2024 | ||||
GSE228842 |
COVID-19 vaccination is associated with attenuation of inflammatory responses during breakthrough disease
|
399 | Irina Chelysheva | Mar 04, 2024 | ||||
GSE228839 |
COVID-19 vaccination is associated with attenuation of inflammatory responses during breakthrough disease [Illumina RNA-Seq]
|
180 | Irina Chelysheva | Mar 04, 2024 | ||||
GSE228840 |
COVID-19 vaccination is associated with attenuation of inflammatory responses during breakthrough disease [long-read RNA-Seq]
|
39 | Irina Chelysheva | Mar 04, 2024 | ||||
GSE228841 |
COVID-19 vaccination is associated with attenuation of inflammatory responses during breakthrough disease [small RNA-Seq]
|
180 | Irina Chelysheva | Mar 04, 2024 | ||||
GSE207012 |
CUT&Tag of KDM4A, B and C in BE2C cells
|
6 | Hongjian Jin | Mar 04, 2024 | ||||
GSE246046 |
Chromatin accessibility and transcriptomic responses to HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids
|
30 | Emanuela Kerschbamer | Mar 04, 2024 | ||||
GSE246044 |
Chromatin accessibility and transcriptomic responses to HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids [ATAC-seq]
|
12 | Emanuela Kerschbamer | Mar 04, 2024 | ||||
GSE246045 |
Chromatin accessibility and transcriptomic responses to HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids [RNA-seq]
|
18 | Emanuela Kerschbamer | Mar 04, 2024 |